Antineoplastic AgentsDrug Screening Assays, AntitumorCell Line, TumorRadiation, IonizingRadiation DosageNeoplasmsRadiation InjuriesDoxorubicinApoptosisDrug Resistance, NeoplasmDose-Response Relationship, RadiationRadiation ToleranceAntineoplastic Agents, PhytogenicRadiationCell SurvivalAntibiotics, AntineoplasticCisplatinDrug Delivery SystemsRadiation ProtectionRadiation MonitoringDrug CarriersTumor Cells, CulturedXenograft Model Antitumor AssaysEllipticinesMice, NudeCell ProliferationCamptothecinEtoposideDNA DamageDrug Resistance, MultiplePaclitaxelInhibitory Concentration 50P-GlycoproteinMolecular StructureDrug DesignDose-Response Relationship, DrugDrug SynergismRadiation OncologyCell CycleDNA Topoisomerases, Type IIGamma RaysProdrugsRadiation-Sensitizing AgentsBreast NeoplasmsTopoisomerase I InhibitorsDaunorubicinEnzyme InhibitorsNanomedicineNanoparticlesCosmic RadiationDrug Evaluation, PreclinicalRadiation Injuries, ExperimentalPlatinumGene Expression Regulation, NeoplasticPlant ExtractsDrug DiscoveryFluorouracilNanocapsulesColonic NeoplasmsRadiation PneumonitisCaspasesAntimetabolites, AntineoplasticOrganoplatinum CompoundsTumor Suppressor Protein p53MitomycinMitoxantroneNeoplasms, Radiation-InducedMolecular Targeted TherapyUltraviolet RaysCaspase 3RadiotherapyCombined Modality TherapyDrugs, InvestigationalProto-Oncogene Proteins c-bcl-2Neoplasms, ExperimentalDNANeoplasm TransplantationDNA RepairMultidrug Resistance-Associated ProteinsIntercalating AgentsBackground RadiationSignal TransductionDNA AdductsTime FactorsCell DeathAntineoplastic Agents, AlkylatingCell DivisionMCF-7 CellsNeoplasm ProteinsHT29 CellsXanthonesLeukemia P388Structure-Activity RelationshipHCT116 CellsTopoisomerase InhibitorsTopoisomerase II InhibitorsGenes, MDRAntineoplastic Combined Chemotherapy ProtocolsATP-Binding Cassette TransportersDrug Resistance